New combo therapy aims to shrink stomach cancer in the abdomen before surgery
NCT ID NCT07304258
First seen Jan 07, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study tests a three-part treatment for people with stomach cancer that has spread to the lining of the abdomen. The treatment combines heated chemotherapy inside the abdomen, standard chemotherapy, and an immunotherapy drug. The goal is to shrink the cancer enough to allow complete surgical removal. The study will include 30 adults who have not had prior treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER PERITONEAL METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fourth Affiliated Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.